ANG Lifesciences India informs about company updates

27 Dec 2017 Evaluate

In reference to the e-mail regarding Discrepancy in Financial Results submitted for the Half Year ended September 2017 under Reg. 33(3)(b) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 dated November 21, 2017, ANG Lifesciences India has informed about the bifurcation of Trade payables as per Schedule III of Companies Act, 2013 in Statement of Assets & Liability.

The above information is a part of company’s filings submitted to BSE.

ANG Lifesciences Share Price

52.80 -2.73 (-4.92%)
09-May-2024 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1493.35
Dr. Reddys Lab 5879.05
Cipla 1358.80
Zydus Lifesciences 967.80
Lupin 1585.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.